Peptide-linked molecular beacons for efficient delivery and rapid mRNA detection in living cells by Nitin, Nitin et al.
Peptide-linked molecular beacons for ef®cient
delivery and rapid mRNA detection in living cells
Nitin Nitin, Philip J. Santangelo, Gloria Kim, Shuming Nie and Gang Bao*
Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332,
USA
Received December 24, 2003; Revised and Accepted March 24, 2004
ABSTRACT
Real-time visualization of speci®c endogenous
mRNA expression in vivo has the potential to
revolutionize medical diagnosis, drug discovery,
developmental and molecular biology. However,
conventional liposome- or dendrimer-based cellular
delivery of molecular probes is inef®cient, slow, and
often detrimental to the probes. Here we demon-
strate the rapid and sensitive detection of RNA in
living cells using peptide-linked molecular beacons
that possess self-delivery, targeting and reporting
functions. We conjugated the TAT peptide to
molecular beacons using three different linkages
and demonstrated that, at relatively low concentra-
tions, these molecular beacon constructs were
internalized into living cells within 30 min with
nearly 100% ef®ciency. Further, peptide-based deliv-
ery did not interfere with either speci®c targeting by
or hybridization-induced ¯uorescence of the
probes. We could therefore detect human GAPDH
and survivin mRNAs in living cells ¯uorescently,
revealing intriguing intracellular localization pat-
terns of mRNA. We clearly demonstrated that
cellular delivery of molecular beacons using the
peptide-based approach has far better performance
compared with conventional transfection methods.
The peptide-linked molecular beacons approach
promises to open new and exciting opportunities in
sensitive gene detection and quanti®cation in vivo.
INTRODUCTION
Quantitative methods to measure gene expression in vitro,
such as real-time PCR and microarray analysis, have
revolutionized molecular biology and drug development (1±
4). These approaches, however, are generally used with
puri®ed DNA or RNA from cell lysates. The ability to detect
and quantify the expression of speci®c endogenous mRNA in
living cells and tissues in real time will offer tremendous
opportunities for biological and disease studies, and will
signi®cantly impact drug discovery and medical diagnostics.
However, currently available technologies for gene detection
in intact cells such as in situ hybridization (ISH) cannot be
used in vivo, since ISH studies rely on washing away unbound
probes to reduce background signal (5,6). To perform gene
detection in living cells, the probes must be able to recognize
the target with high speci®city, convert target recognition
directly into a measurable signal with high signal-to-back-
ground (S/B) ratio, and allow for differentiation between true
and false positive events (7). Probes must also be delivered
into living cells with high ef®ciencies.
Among the technologies currently under development for
living cell gene detection and quanti®cation, the most
promising one is perhaps molecular beacons. Molecular
beacons are dual-labeled antisense oligonucleotide (ODN)
probes with a ¯uorophore at one end and a quencher at the
other end (8,9). In contrast to ¯uorescently labeled linear ODN
probes, molecular beacons are designed to form a stem±loop
(hairpin) structure in the absence of complementary target so
that ¯uorescence of the ¯uorophore is quenched. Hybridiz-
ation with target mRNA opens the hairpin and physically
separates the reporter from quencher, allowing a ¯uorescence
signal to be emitted upon excitation. Thus, molecular beacons
enable a homogenous assay format where background is low
without the need to wash away free probes. However, to detect
mRNA in vivo, one needs to deliver molecular beacons into
living cells with high ef®ciencies and fast kinetics.
Conventional delivery approaches are based on DNA
transfection techniques, such as those employing liposomes
or dendrimers. These approaches are inef®cient (<80%) (10),
slow (delivery times ~4 h), and can potentially trap molecular
beacons in the endosomes and degrade them in the lysosomes,
signi®cantly increasing the background signal (11). The long
delivery time also gives rise to signi®cant degradation of
cytoplasmic molecular beacons by nuclease, further increas-
ing false positive detection (12). Although the reversible
membrane permeabilization method using streptolysin O
(SLO) is faster (~2 h) and not based on endocytosis (13), it
can only be used in ex vivo cellular assays. Other delivery
methods, such as microinjection (14) and electroporation (15)
are invasive and may cause severe damage to cells. Further,
microinjection is labor-intensive and only practical for
studying a small number of cells.
To overcome these dif®culties, we have developed novel
peptide-linked molecular beacons that can quickly and
ef®ciently enter living cells without the need of any other
delivery reagent. Recent research has identi®ed several small
regions (9±16 amino acids) of proteins called protein
transduction domains (PTDs) or cell penetrating peptides
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(CPPs) that confer the ability to traverse biological mem-
branes ef®ciently (16±18). Here we show that conjugating one
such peptide (TAT-1) to molecular beacons yields a multi-
functional probe that can enter into living cells with nearly
100% ef®ciency, fast (~30 min) delivery kinetics, and the
ability to localize in cell cytoplasm. Further, these peptide-
linked molecular beacons function well for mRNA detection
in living cells. This novel molecular beacon design can thus
provide a powerful means for rapid detection of gene
expression in living cells and tissues in real time, with high
speci®city and sensitivity.
MATERIALS AND METHODS
Design of peptide-linked molecular beacons
We designed and synthesized peptide-linked molecular
beacons targeting the human GAPDH (glyceraldehyde 3-
phosphate dehydrogenase) and survivin mRNAs, as well as
molecular beacons with a `random' probe sequence. The
speci®c design of these molecular beacons, and the sequence
of the 11 amino-acid TAT-1 peptide used in the study are
shown in Table 1. GAPDH is a glycolytic protein that has a
diverse range of activities in mammalian cells including
membrane fusion, microtubule bundling, nuclear RNA export,
DNA replication and repair (19). These activities suggest that
GAPDH is involved in apoptosis, age-related neurodegenera-
tive disease, prostate cancer and viral pathogenesis. Survivin
is a member of the inhibitor of apoptosis protein (IAP) family
and also regulates cell division (20). The GAPDH beacon is
comprised of a 19-base probe domain targeting the Exon 6
region of GAPDH gene ¯anked by complementary 5-base
sequences that hybridize to form the stem. The survivin
beacon has a 16-base target sequence with a similar design of
the stem. The `random' beacon was designed as a negative
control, with a 17-base probe sequence that does not have any
match in the entire human genome. To ensure good target
accessibility, we typically design and test molecular beacons
complementary to different segments of the same mRNA
molecule to avoid targeting sequences that are occupied by
RNA-binding proteins or where double-stranded RNA is
formed.
Three conjugation strategies were developed in attaching the
delivery peptide to molecular beacons, as illustrated in Figure 1.
In the ®rst approach (Fig. 1A), peptides were linked to a
molecular beacon through a streptavidin±biotin bridge by
introducing a modi®ed oligonucleotide, biotin-dT, to the
quencher arm of the stem through a carbon-12 spacer.
The peptide-linked molecular beacon consisted of the
biotin-modi®ed molecular beacon, a streptavidin molecule
and biotin-modi®ed TAT-1 peptides. Since each streptavidin
molecule has four biotin-binding sites, we were able to link
biotin-modi®ed molecular beacons and delivery peptides on the
same streptavidin molecule. The stoichiometry was controlled
so that the probability of having more than one molecular
beacon linked to the same streptavidin is small. In the second
design (Fig. 1B), we placed a thiol group on the quencher arm
of the molecular beacon stem through a carbon linker; the thiol
group then reacted with a maleimide group added to the C
terminus of the peptide to form a thiol±maleimide linkage
(Fig. 1B). Both the streptavidin±biotin bridge and the thiol±
maleimide linkage are stable in the cell cytoplasm.
Table 1. Design of peptide-linked molecular beacons
Peptide







Underlined bases are bases added to create the stem domain of a molecular beacon.
Figure 1. A schematic illustration of three different conjugation schemes
for linking the delivery peptide to molecular beacons. (A) The streptavidin±
biotin linkage in which a molecular beacon is modi®ed by introducing a
biotin-dT to the quencher arm of the stem through a carbon-12 spacer. The
biotin-modi®ed peptides are linked to the modi®ed molecular beacon
through a streptavidin molecule, which has four biotin-binding sites. (B) The
thiol±maleimide linkage in which the quencher arm of the molecular beacon
stem is modi®ed by adding a thiol group which can react with a maleimide
group placed to the C terminus of the peptide to form a direct, stable
linkage. (C) The cleavable disul®de bridge in which the peptide is modi®ed
by adding a cysteine residue at the C terminus which forms a disul®de
bridge with the thiol-modi®ed molecular beacon. This disul®de bridge
design allows the peptide to be cleaved from the molecular beacon by the
reducing environment of the cytoplasm.
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We and others have demonstrated that, for certain cell
types, CPPs including TAT-1 peptide tend to carry cargos into
cell nucleus (18,21). While this may be useful in detecting
nuclear RNA targets such as polyadenylated nuclear RNA
(PAN), in most applications however, the target mRNAs are in
the cytoplasm, so should be the molecular beacons. Thus, as
the third approach, we functionalized the TAT-1 peptide by
adding a cysteine residue at the C terminus which forms a
disul®de bridge with the thiol-modi®ed molecular beacon as
shown in Figure 1C. This cleavable design was based on the
rationale that the reducing environment of the cytoplasm will
cleave the disul®de bond once the construct enters the cell,
thereby separating peptide from probe. This has been demon-
strated by Hallbrink et al. using a TAT-peptide linked cargo±
quencher construct (22). Speci®cally, a peptide-conjugated,
¯uorescently-labeled cargo was linked to a ¯uorescence
quencher through a disul®de bond, resulting in a reduction-
sensitive construct. Upon internalization into Bowes human
melanoma cells, the disul®de bond was quickly reduced, as
indicated by the increased ¯uorescence intensity. Since fast
cleavage of disul®de bridge inside living cells is well
documented (23), we believe that, once the cleavable,
peptide-linked molecular beacons (Fig. 1C) are inside the
cell, the disul®de bridge will be reduced, leaving the
molecular beacons in the cytoplasm.
Peptide conjugation
In the design shown in Figure 1A, streptavidin was chosen as a
linker molecule because of its high af®nity for biotin and
availability of multiple biotin-binding sites. The modi®ed
nucleotide (dT) at the third base from the 3¢ end on the
quencher arm of the stem was linked to biotin through a 12-
carbon spacer, and the biotin-modi®ed peptides were conju-
gated to the biotin-modi®ed molecular beacon through
binding between biotin and streptavidin. The peptide-linked
molecular beacon complex was dialyzed with PBS (13)
overnight using a Slide-A-Lyzer Dialysis Unit, 10K MWCO
(Pierce Biotech Inc., Rockford, IL) to exchange the buffer and
to remove the unconjugated peptide. The modi®ed molecular
beacons were synthesized at Integrated DNA Technologies,
Inc. (Coralville, IA) and MWG Biotech, Inc. (High Point,
NC), and the modi®ed peptides were synthesized by
Invitrogen Inc. (Carlsbad, CA) and Synpep Corporation
(Dublin, CA).
In the direct linkage approaches shown in Figure 1B and C,
the same position on the quencher arm of the stem bore a
modi®ed nucleotide dT-amine group with a 6-carbon spacer.
To generate a direct, stable linkage between the peptide and
molecular beacon, the peptide was modi®ed with a maleimide
group at its C terminus. Amine-modi®ed molecular beacons
were reacted in PBS buffer with a 2-fold molar excess of the
heterobifunctional crosslinker SPDP, N-Succinimidyl 3-(2-
pyridyldithio)propionate (Sigma±Aldrich) for 2 h, followed by
reduction with a 20-fold molar excess of TCEP, 3,3¢,3¢¢-
Phosphinidyne-tripropionic acid hydrochloride (Sigma±
Aldrich), to create a free thiol (±SH) functional group. This
thiolated beacon was then reacted with maleimide-modi®ed
peptide to form a stable chemical bridge between the beacon
and the peptide. The peptide-linked molecular beacon com-
plex was dialyzed overnight using Slide-A-Lyzer Dialysis
Unit, 10K MWCO (Pierce Biotech Inc.) to remove the
unconjugated peptide. A similar approach was used in forming
a cleavable disul®de bridge between the cysteine-modi®ed
peptide and the amine-modi®ed molecular beacon. To reduce
the probability of forming beacon±beacon conjugates, a higher
(1.53) concentration of peptides was used compared with that
of beacons. Further, the positive charge of peptides helped
prevent homodimerization of peptides.
Solution assays of hybridization kinetics and S/B ratio
Measurement of hybridization kinetics and S/B ratio of
peptide-linked molecular beacons was carried out using a
SAFIRE microplate monochromator reader (TECAN,
Austria). For kinetic studies, 200 nM peptide-linked molecular
beacons was mixed with 1 mM complementary oligonucle-
otide target at 37°C and the ¯uorescence intensity was
recorded as a function of time for conventional molecular
beacons, direct linked (stable and cleavable) peptide±
molecular beacon complexes, and streptavidin-linked
peptide±molecular beacon complex. To determine the S/B
ratios, 200 nM conventional and peptide-linked molecular
beacons were mixed with 200 nM of complementary target,
respectively in the microplate reader, and the ¯uorescence
intensity at equilibrium was recorded. The ¯uorescence signal
of each molecular beacon type (conventional and peptide-
linked) in the absence of target was recorded as the
background signal. All solution assays were performed in
13 PBS buffer.
Cellular delivery of peptide-linked molecular beacons
Primary human dermal ®broblast (HDF) cells (Cambrex, NJ)
and a pancreatic cancer cell line MiaPaca-2 (ATCC, VA) were
used for this study. These cells were cultured in an eight-well
Nalge Nunc culture plate with a glass coverslip bottom in their
respective cell culture media for 24 h prior to experiments.
Delivery assays were performed by incubating cells at 37°C
with the media containing peptide-linked molecular beacons.
For molecular beacons targeting GAPDH, peptide-linked
molecular beacons with three different concentrations (0.25,
0.5 and 1.0 mM) were incubated with HDF cells for 30, 60 and
90 min. For molecular beacons targeting survivin, 0.5 mM of
peptide-linked molecular beacons were incubated with HDF
and MiaPaca-2 cells for 30 min. For all assays, the cells were
washed twice with PBS to remove the incubation medium and
placed in fresh medium for ¯uorescence imaging, which was
carried out using a confocal microscope (Axiovert LSM-100,
Zeiss).
Fluorescence in situ hybridization
Normal human dermal ®broblast cells were cultured in eight-
well chambered cover slides for 24 h in normal growth
medium (FGM-2 Cambrex Co.) and then washing with 13
PBS (without Ca or Mg). The slide was ®xed in 100%
methanol at ±20°C for 10 min. After removing the methanol,
the slides were allowed to air dry and stored overnight at
±80°C. In situ hybridization assays were then performed by
®rst washing the slides for 5 min in 13 PBS and hybridizing
them overnight at 37°C in 13 PBS (no Ca or Mg) containing
200 nM of unmodi®ed GAPDH-targeting molecular beacons.
After removing the hybridization solution with washing and
adding 13 PBS, the cells were imaged using an Axiovert 100
epi-¯uorescent microscope.
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Delivery of molecular beacons using commercial
transfection reagents
To compare the ef®ciency and functionality of different
delivery methods, we used three commercially available
transfection reagents: Effectene (Qiagen), Superfect (Qiagen)
and Oligofectamine (Invitrogen). Transfection assays were
carried out according to the procedure recommended by
respective suppliers; both primary HDF cells and MiaPaca-2
pancreatic cancer cells were incubated with conventional
(unmodi®ed) molecular beacons for 0.5, 2 and 3.5 h.
RESULTS AND DISCUSSION
Hybridization kinetics of peptide-linked molecular
beacons
To determine the effect of peptide conjugation on molecular
beacon function, in-solution hybridization assays were carried
out for the binding kinetics of peptide-linked molecular
beacons with different conjugation methods. One concern was
that, when the positively charged TAT-1 peptide is conjugated
to a molecular beacon, it might interact with the negatively
charged hairpin oligonucleotide, thus interfering with proper
probe±target binding. Shown in Figure 2A are normalized
¯uorescence intensity versus time curves as a result of
probe±target hybridization for unmodi®ed GAPDH-targeting
molecular beacons and peptide-linked molecular beacons with
the streptavidin±biotin linkage, the stable thiol±maleimide
linkage, and the cleavable disul®de bridge. Peptide-linked
molecular beacons with the thiol±maleimide linkage had
almost exactly the same probe±target hybridization kinetics as
unmodi®ed molecular beacons (black and green curves,
respectively in Fig. 2A), indicating that the conjugation of
peptide using the thiol±maleimide linkage has essentially no
effect on the functionality of molecular beacons. Molecular
beacons with the cleavable disul®de bridge also behaved
similarly to the unmodi®ed ones. With streptavidin±biotin
linkage, the hybridization kinetics of peptide-linked molecular
beacons was slightly slower, but it did not affect the signal
level, as can be seen from Figure 2A. It is possible that the
streptavidin molecule, whose size is comparable to that of the
molecule beacon, may have sterically hindered binding
between the target and the hairpin probe, leading to a slightly
reduced hybridization kinetic rate. The effect of different
conjugation methods on S/B ratio is relatively small (Fig. 2B),
although the S/B for peptide-linked molecular beacons was
slightly lower than that of the unmodi®ed ones. Taken
together, the results shown in Figure 2 clearly indicate that
conjugation of peptide to molecular beacons did not impair
their normal function.
Detection of GAPDH mRNA using peptide-linked
molecular beacons
To demonstrate the self-delivery and mRNA targeting func-
tions of peptide-linked molecular beacons, we ®rst detected
mRNA of a housekeeping gene human GAPDH in normal
human dermal ®broblast (HDF) cells. After just 30 min of
incubation with TAT-peptide conjugated GAPDH-targeting
molecular beacons, we observed clear and localized ¯uores-
cence signal in HDF cells as a result of molecular beacon-
target mRNA hybridization for all three conjugation schemes,
i.e. thiol±maleimide (Fig. 3A), disul®de bridge (Fig. 3B) and
streptavidin±biotin (Fig. 3C). In contrast, peptide-linked
random-sequence molecular beacons with streptavidin±biotin
conjugation gave essentially no signal 30 min after delivery
(Fig. 3D). Similar results were obtained using random-
sequence molecular beacons with thiol±maleimide and
disul®de linkages for peptide (data not shown). This demon-
strates that peptide-linked molecular beacons remained highly
speci®c in living cells after internalization. Further, we found
that GAPDH mRNAs displayed a very intriguing ®lament-like
localization pattern in HDF cells, with a clear tendency of
surrounding the cell nucleus and following the cell mor-
phology (Fig. 3A±C). Interestingly, molecular beacons with
the cleavable (thiol±cysteine disul®de bridge) design seemed
Figure 2. Probe±target hybridization kinetics of unmodi®ed and peptide-
linked molecular beacons. (A) Normalized ¯uorescence intensity as a func-
tion of time for unmodi®ed molecular beacons, and for the three types of
peptide-linked molecular beacons. Note that the probe±target hybridization
kinetic curves of peptide-linked molecular beacons with the thiol±maleimide
linkage (black curve) and unmodi®ed molecular beacons (green curve) are
almost identical. (B) S/B ratios (red) of probe±target hybridization for
peptide-linked molecular beacons with different conjugation methods. The
S/B ratios for thiol-modi®ed and biotin-modi®ed molecular beacons (blue)
without peptide are also shown for comparison. The hybridization kinetics
and S/B ratio did not change much, indicating that the functionality of the
molecular beacons was not impaired by peptide conjugation.
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to give better localization patterns than those with the thiol±
maleimide linkage, and the latter seemed to perform better
than molecular beacons with the streptavidin±biotin linkage.
Cleavage of the delivery peptide from the construct may have
provided molecular beacons a better access to target mRNA
molecules, although more studies of this phenomenon are
required to validate this assumption. It is likely that a
molecular beacon with a relatively bulky streptavidin mol-
ecule is less able to penetrate into the secondary structure of
the GAPDH mRNA, thus reducing its ability to seek out its
targets. Almost all the HDF cells exposed to GAPDH peptide-
linked molecular beacons showed a strong ¯uorescence signal,
implying a near 100% delivery ef®ciency (data not shown).
Similar results were obtained after 60 min of incubation
(Fig. 3E±H). About the same level of ¯uorescence was
observed for GAPDH-targeting molecular beacons with
different linkages for peptide, whereas the random sequence
molecular beacons did not give much signal. Even after
90 min, there was essentially no increase in the signal level
(data not shown), indicating that most of the peptide-linked
molecular beacons entered the HDF cells within the ®rst
30 min. Further, ¯uorescence signal levels and mRNA
localization patterns in HDF cells were similar for experi-
ments at three different nominal molecular beacon concen-
trations (0.25, 0.5 and 1.0 mM). As a result of the peptide
conjugation process, it was estimated that, with 0.25 mM
nominal molecular beacon concentration, the actual concen-
tration of peptide-linked molecular beacons used in the assay
was about 150±200 nM.
Comparison with in situ hybridization
To correlate the results of the present method with a traditional
method, we performed ¯uorescence in situ hybridization
(FISH) assays targeting GAPDH mRNA in ®xed HDF cells.
The probes used in the FISH assays were ¯uorescently labeled
linear probes (5¢-Cy5-GAGTCCTTCCACGATACCA-3¢) that
have the same probe sequence as the GAPDH-targeting
molecular beacon. As demonstrated in Figure 4A, the
¯uorescence image obtained in FISH assays of GAPDH
mRNA in HDF cells gave a ®lamentous localization pattern
similar to that shown in Figure 3, con®rming that the mRNA
localization revealed in this study is not an artifact. However,
the ¯uorescence signal as a result of FISH was not as sharp as
that in living cell assays. Since the probes entered into both the
cell cytoplasm and nucleus during FISH, a diffused ¯uores-
cence signal appeared in the ®xed HDF cell nuclei (Fig. 4A).
This is in contrast to the living cell images shown in Figure 3
where very low signal can be observed in the cell nucleus. We
believe that this diffused signal may re¯ect the high
abundance as well as a rather uniform distribution of
GAPDH mRNA in cell nucleus. As a negative control, we
performed a FISH assay with ¯uorescently labeled linear
Poly-A probes (5¢-Cy5-AAAAAAAAAAAAAAAAAA-3¢)
Figure 3. Detection of GAPDH mRNA in HDF cells using 0.5 mM of peptide-linked molecular beacons. (A±C) Fluorescence images of HDF cells after
30 min of incubation with TAT-peptide conjugated, GAPDH-targeting molecular beacons, with (A) thiol±maleimide, (B) disul®de bridge and (C)
streptavidin±biotin linkages. (D) With peptide-linked random-sequence molecular beacons, there was essentially no detectable signal 30 min after delivery.
(E±G) Fluorescence images of HDF cells after 60 min of incubation of peptide-linked, GAPDH-targeting molecular beacons with (E) thiol±maleimide,
(F) disul®de bridge and (G) streptavidin±biotin linkages. The signal level of peptide-linked random-sequence molecular beacons after 60 min is shown in (H).
Clearly, the ¯uorescence signal level did not increase when incubation time was doubled, indicating that most of the molecular beacons internalized within
the ®rst 30 min. Note the intriguing GAPDH mRNA localization patterns shown in (A±C) and (E±G).
Figure 4. Control studies using ¯uorescence in situ hybridization (FISH).
(A) Detection of GAPDH mRNA in ®xed HDF cells. The ®lamentous local-
ization pattern of GAPDH mRNA was similar to that revealed in living cell
assays, although the signal was not as sharp. Note the diffused ¯uorescence
signal in cell nuclei. (B) A negative control study of the FISH assay using
¯uorescently labeled linear Poly-A probes resulted in very low background.
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and the resulting background signal was very low, as can be
seen from Figure 4B. This further con®rmed that the
¯uorescence signal observed in our live cell and ®xed cell
studies of speci®c mRNA detection was truly due to probe/
target hybridization.
Detection of survivin mRNA
To demonstrate the ability of molecular beacons to determine
gene transcription levels, we observed expression of survivin
mRNA in live HDF and MiaPaca-2 cells. We and others have
demonstrated that the survivin expression level is very low in
HDF cells, whereas in MiaPaCa-2 cells the level is relatively
high. After 60 min of incubation with peptide-linked mol-
ecular beacons, the ¯uorescence signal in MiaPaca-2 cells was
quite high, as shown in Figure 5A, but in HDF cells, only a
very low ¯uorescence signal can be observed (Fig. 5C). In
addition, survivin mRNAs showed an intriguing localization
pattern, i.e. the survivin mRNA molecules in MiaPaCa-2 cells
seemed to be concentrated near one side of the cell nucleus
(Fig. 5B). However, with very low expression level, Survivin
mRNA localized in HDF in a similar fashion (Fig. 5C).
Previous research has suggested that the expression level and
localization of survivin may be an important indicator for
cancer progression or prognosis (24).
Comparison with conventional transfection methods
As mentioned above, cellular delivery of molecular beacons
using conventional transfection methods, either liposome
based or dendrimer based, typically requires 3±4 h of
incubation during which a high level of background signal is
generated. To compare the ef®ciency of delivery and the
stability of molecular beacons during internalization, we
performed delivery studies of unmodi®ed GAPDH-targeting
molecular beacons with three commercially available
transfection reagents: Superfect (dendrimer-based), Oligofect-
amine (liposome-based), and Effectene (liposome based), and
followed all the manufacturers' instructions. When ¯uores-
cence in HDF cells was observed after 30 min of GAPDH
beacon delivery using Superfect, Oligofectamine or Effectene,
there was essentially no signal (data not shown). We found
that, after 3.5 h of transfection with Superfect, the molecular
beacons gave strong signal in HDF cells. However, the
¯uorescence image had different characteristics from that of
peptide-linked molecular beacons. Speci®cally, the ¯uores-
cence signals were concentrated in random `bright spots' in
both cytoplasm and nucleus (Fig. 6A), suggesting that
molecular beacons were trapped and degraded by endosomes,
lysosomes and nucleus. Even more disturbing is that the
random-sequence molecular beacons showed similar ¯uores-
cence signal levels and `bright spots' in HDF cells (Fig. 6D),
indicating that the signals in both cases were largely due to
molecular beacon degradation. With Oligofectamine transfec-
tion, the results after 3.5-h incubation were even worse: only
highly concentrated bright spots were present in the HDF
cells, with a similar signal level generated by GAPDH-
targeting and random-sequence molecular beacons (Fig. 6B
and E). Using Effectene for molecular beacon delivery gave
¯uorescence images (Fig. 6C and F with GAPDH-targeting
and random-sequence molecular beacons, respectively) that
resembled the corresponding images shown in Figure 6A and
E. Clearly, caution must be taken in using these transfection
methods in delivering molecular beacons for living cell gene
detection assays.
We have clearly demonstrated that cellular delivery of
molecular beacons using the peptide-based approach has far
better performance compared with conventional transfection
methods. This opens new opportunities that become possible
only with peptide-linked molecular beacons. For example, the
fast delivery kinetics (~30 min) and high ef®ciency in probe
internalization, combined with the high speci®city and S/B
ratio of molecular beacon makes the peptide-linked molecular
beacon probes a unique and novel system for studying gene
expression in living cells in real time. We and other have
shown that when delivered through the endocytic pathway
(e.g. liposome-based transfection), antisense oligonucleotide
probes tend to be trapped inside endocytic vesicles and
degraded in the endosomes and lysosomes by nucleases (25).
Peptide-based internalization has the potential to avoid the
endocytic pathway, therefore reducing false-positive signals
due to nuclease degradation. Consequently, ODN backbone
modi®cations of the probe such as the use of 2¢-O-methyl
modi®ed molecular beacons may not be necessary. As
demonstrated in our study, combining fast probe delivery
with prompt optical imaging, a high S/B can be realized in live
cell mRNA detection. Although the dual FRET molecular
beacons approach (26,27) can also signi®cantly reduce the
false-positive signal and give rise to enhanced sensitivity in
mRNA detection in living cells, it requires simultaneous
hybridization of two probes on the same target and typically
takes much longer than 30 min. The peptide-linked molecular
beacons approach, on the other hand, is faster (~30 min) and
simpler, which may be more suitable for certain applications,
including basic biological studies of mRNA expression level
in living cells in response to drug molecules, toxin and
external stimuli, the knock-down effect of RNAi, and disease
detection and diagnosis. Using NIR ¯uorophores as the
reporter, peptide-linked molecular beacons have the potential
to become a powerful tool for shallow tissue molecular
imaging with high sensitivity and spatial resolution.
Although our results demonstrated the high ef®ciency of
peptide-based probe delivery, the underlying mechanism of
cell membrane penetration remains largely unknown. Some
studies suggest that cell entry is independent of the endosomal
pathway (28) with the notion that the internalization is much
Figure 5. Detection of survivin mRNA in live HDF and MiaPaca-2 cells.
(A) A strong ¯uorescence signal was observed in MiaPaca-2 cells after
60 min of incubation with peptide-linked molecular beacons. Note that
essentially all cells showed ¯uorescence. (B) Survivin mRNA molecules in
MiaPaca-2 cells seemed to be concentrated near one side of the cell nucleus
of HDF cells. (C) Only a very low ¯uorescence signal can be observed in
HDF cells, but with a survivin mRNA localization pattern.
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faster than known endocytotic processes (29), whereas others
suggest that the CPP-induced cargo internalization is due to
classical endocytosis (30,31). One possibility is that the initial
interaction between the peptide and cell surface is due to
electrostatic forces, but subsequent cell membrane penetration
is mediated by glycosaminoglycans (32). However, many
questions still remain open. For example, for certain cell lines
the TAT-1 and other peptides have the ability to deliver cargos
into cell nuclei, suggesting a directed motion in the cytoplasm.
It is still unclear whether different CPPs follow a common
mechanism or have different pathways. More biochemical and
biophysical studies of the CPP-based delivery mechanism are
clearly warranted.
There are many challenges in quantifying mRNA expres-
sion in living cells, including the need to create an internal
control for ¯uorescence intensity of the reporter ¯uorophore in
the intracellular environment, and determine the fraction of
mRNA molecules hybridized with probes. The detection
sensitivity is also affected by the properties of ¯uorophore,
¯uorescence detection method, the optical imaging instru-
mentation used and background signal. It has been suggested
that the molecular beacon-based approach could detect as low
as 10 mRNA molecules in a single cell (14). Alternatively, the
average mRNA expression over a large number of cells can be
obtained using FACS (Fluorescence Activated Cell Sorter) to
yield more reproducible and statistically more signi®cant
results.
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